Is COGT or DOCS more profitable?

DOCS runs the higher net margin — COGT at 0.00% versus DOCS at 25.48%.

How have COGT and DOCS total returns compared?

Over the past 5 years, COGT delivered 28.51% and DOCS delivered -18.23% annualized total return. Past performance doesn't predict future results.

Cogent Biosciences, Inc. (COGT) vs Doximity, Inc. (DOCS)

A side-by-side comparison of Cogent Biosciences, Inc. and Doximity, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

COGT

Cogent Biosciences, Inc.

$5.27B

$30.87HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

DOCS

Doximity, Inc.

$5.35B

$28.58HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — COGT vs DOCS

growth of $100 · dividends reinvested · last 5y

COGT +261.1% (+29.3%/yr)DOCS -46.1% (-11.6%/yr)COGT compounded faster over this window

Log scale — wide-divergence pair

COGT DOCS

COGT vs DOCS: by the numbers

•DOCS is the larger company ($5.35B vs $5.27B market cap).
•DOCS is profitable (25.48% net margin) while COGT runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	COGT	DOCS
P/E ratio	N/A	33.62
Forward P/E	N/A	21.21
PEG ratio	N/A	0.64
P/S ratio	N/A	8.15
P/B ratio	11.28	5.83
EV / EBITDA	N/A	24.01
FCF yield	N/A	5.60%

Profitability

Metric	COGT	DOCS
Gross margin	0.00%	88.07%
Operating margin	0.00%	29.60%
Net margin	0.00%	25.48%
ROE	-70.85%	18.24%
ROIC	-50.09%	15.35%

Growth (annualized)

Metric	COGT	DOCS
Revenue CAGR (5Y)	N/A	21.94%
EPS CAGR (5Y)	N/A	54.32%
FCF CAGR (5Y)	N/A	23.75%
Total return CAGR (5Y)	28.51%	-18.23%

Frequently asked

Is COGT or DOCS more profitable?: DOCS runs the higher net margin — COGT at 0.00% versus DOCS at 25.48%.
How have COGT and DOCS total returns compared?: Over the past 5 years, COGT delivered 28.51% and DOCS delivered -18.23% annualized total return. Past performance doesn't predict future results.

Go deeper

Full COGT analysis Full DOCS analysis Interactive comparison tool

Dig into the metrics

Doximity P/E ratio Cogent Biosciences ROE Doximity ROE Cogent Biosciences operating margin Doximity operating margin Cogent Biosciences revenue growth Doximity revenue growth Cogent Biosciences free cash flow Doximity free cash flow

Cogent Biosciences & Doximity appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.